Hailin Zou

587 total citations
20 papers, 400 citations indexed

About

Hailin Zou is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Hailin Zou has authored 20 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cell Biology and 5 papers in Oncology. Recurrent topics in Hailin Zou's work include Hippo pathway signaling and YAP/TAZ (9 papers), Epigenetics and DNA Methylation (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Hailin Zou is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (9 papers), Epigenetics and DNA Methylation (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Hailin Zou collaborates with scholars based in China, United States and Hong Kong. Hailin Zou's co-authors include Juan Luo, Yibo Guo, Peng Li, Liang Deng, Tongyu Tong, Yihang Pan, Jingxuan Pan, Yun Wang, Chengming Zhu and Liping Ye and has published in prestigious journals such as Oncogene, British Journal of Cancer and Cellular and Molecular Life Sciences.

In The Last Decade

Hailin Zou

15 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hailin Zou China 10 274 127 94 68 36 20 400
С. С. Шушанов Russia 10 256 0.9× 54 0.4× 99 1.1× 103 1.5× 17 0.5× 26 393
Man Li China 10 260 0.9× 50 0.4× 81 0.9× 52 0.8× 40 1.1× 23 349
Evangelia Pantazaka Greece 13 253 0.9× 103 0.8× 89 0.9× 85 1.3× 39 1.1× 22 402
Malathi Narayan United States 11 226 0.8× 53 0.4× 116 1.2× 54 0.8× 12 0.3× 16 414
Robyn Loureiro United States 9 282 1.0× 63 0.5× 63 0.7× 76 1.1× 23 0.6× 14 451
Naomi Brook Australia 5 271 1.0× 36 0.3× 190 2.0× 94 1.4× 56 1.6× 8 439
Rosario Yerbes Spain 11 307 1.1× 89 0.7× 112 1.2× 61 0.9× 18 0.5× 16 411
Laurent Beuret France 8 238 0.9× 227 1.8× 73 0.8× 48 0.7× 30 0.8× 10 434
Yuko Murakami‐Tonami Japan 14 385 1.4× 126 1.0× 68 0.7× 57 0.8× 36 1.0× 25 493

Countries citing papers authored by Hailin Zou

Since Specialization
Citations

This map shows the geographic impact of Hailin Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailin Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailin Zou more than expected).

Fields of papers citing papers by Hailin Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailin Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailin Zou. The network helps show where Hailin Zou may publish in the future.

Co-authorship network of co-authors of Hailin Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Hailin Zou. A scholar is included among the top collaborators of Hailin Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailin Zou. Hailin Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Hailin, Xiaoling Dai, Tongyu Tong, et al.. (2025). PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells. Science Signaling. 18(909). eadx2532–eadx2532.
2.
Zou, Hailin, Xiaoting Yang, Qingyuan Zhang, et al.. (2025). PRMT2 promotes tumorigenic phenotypes through the Wnt signaling pathway and drives immune suppression in Colorectal cancer. Cancer Letters. 632. 217967–217967.
3.
Zhong, Zhiyuan, Yifei Duan, Cheng Ouyang, et al.. (2025). Advances and Challenges in Targeted Therapy and Its Combination Strategies for Leukemia. Biomedicines. 13(7). 1652–1652.
4.
Tong, Tongyu, Hanqi Lei, Zheng Yang, et al.. (2025). HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer. Oncogene. 44(41). 3895–3908.
5.
Huang, Mengjun, et al.. (2025). Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophages. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(7). 167974–167974. 1 indexed citations
6.
Huang, Mengjun, Hanqi Lei, Tongyu Tong, et al.. (2025). CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3 ‐Mediated Mitophagy. Cell Proliferation. 59(2). e70091–e70091.
7.
Zou, Hailin, Juan Luo, Yibo Guo, et al.. (2024). Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer. Drug Resistance Updates. 73. 101051–101051. 15 indexed citations
8.
Liu, Shuhao, Yong Liu, Yijun Zhou, et al.. (2024). NSUN5 promotes tumorigenic phenotypes through the WNT signaling pathway and immunosuppression of CD8+ T cells in gastric cancer. Cellular Signalling. 124. 111475–111475. 7 indexed citations
9.
Luo, Juan, Liang Deng, Hailin Zou, et al.. (2023). New insights into the ambivalent role of YAP/TAZ in human cancers. Journal of Experimental & Clinical Cancer Research. 42(1). 130–130. 38 indexed citations
10.
Zou, Hailin, Juan Luo, Yibo Guo, et al.. (2023). Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer. Cellular and Molecular Life Sciences. 80(2). 41–41. 21 indexed citations
11.
Luo, Juan, Hailin Zou, Yibo Guo, et al.. (2023). The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. British Journal of Cancer. 128(9). 1611–1624. 45 indexed citations
12.
Luo, Juan, Hailin Zou, Yibo Guo, et al.. (2022). BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids. Cell Death Discovery. 8(1). 47–47. 23 indexed citations
13.
Zou, Hailin, Juan Luo, Yibo Guo, et al.. (2022). RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7. Oncogene. 41(11). 1657–1672. 41 indexed citations
14.
Luo, Juan, Hailin Zou, Yibo Guo, et al.. (2022). SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. Breast Cancer Research. 24(1). 99–99. 71 indexed citations
15.
Guo, Yibo, et al.. (2021). Context-dependent transcriptional regulations of YAP/TAZ in cancer. Cancer Letters. 527. 164–173. 33 indexed citations
16.
Luo, Juan, Hailin Zou, & Peng Li. (2021). Src-Yap1 signaling axis controls the trophectoderm and epiblast lineage differentiation in mouse embryonic stem cells. Stem Cell Research. 54. 102413–102413. 5 indexed citations
17.
Zhou, Jingfeng, Shenglan Liu, Yun Wang, et al.. (2021). Correction to: Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma. Molecular Cancer. 20(1). 47–47. 2 indexed citations
18.
Luo, Juan, Hailin Zou, Liang Deng, et al.. (2021). Lin28 Inhibits the Differentiation from Mouse Embryonic Stem Cells to Glial Lineage Cells through Upregulation of Yap1. Stem Cells International. 2021. 1–12. 6 indexed citations
19.
Jin, Bei, Ping Zhang, Hailin Zou, et al.. (2020). Verification of EZH2 as a druggable target in metastatic uveal melanoma. Molecular Cancer. 19(1). 52–52. 43 indexed citations
20.
Zhou, Jingfeng, Shenglan Liu, Yun Wang, et al.. (2019). Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma. Molecular Cancer. 18(1). 159–159. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by С. С. Шушанов Breakdown of academic impact, for papers by Man Li Breakdown of academic impact, for papers by Evangelia Pantazaka Breakdown of academic impact, for papers by Malathi Narayan Breakdown of academic impact, for papers by Robyn Loureiro Breakdown of academic impact, for papers by Naomi Brook Breakdown of academic impact, for papers by Rosario Yerbes Breakdown of academic impact, for papers by Laurent Beuret Breakdown of academic impact, for papers by Yuko Murakami‐Tonami
Rankless by CCL
2026